Roach's mathematical equations in predicting pathological stage in men with clinically localized prostate cancer

被引:6
|
作者
Medica, M [1 ]
Giglio, M [1 ]
Germinale, F [1 ]
Timossi, L [1 ]
Romagnoli, A [1 ]
Bertolotto, F [1 ]
Carmignani, G [1 ]
机构
[1] Univ Genoa, San Martino Hosp, Luciano Giuliani Dept Urol, I-16126 Genoa, Italy
关键词
clinical staging; prostate cancer; therapeutic choice;
D O I
10.1177/030089160108700304
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims and background: The therapeutic choice in patients with clinically: localized prostate cancer depends on preoperative clinical stage. Diagnostic instruments currently available for such an evaluation - considered separately - have not shown enough efficacy. Roach has recently introduced three simple mathematical equations that - on the basis of prostate-specific antigen and the biopsy Gleason score - are aimed at calculating the definitive pathological stage. We retrospectively analyzed our radical prostatectomy data base to assess the accuracy of the equations in predicting the final stage in patients with clinically localized prostate cancer. Methods study design: The study included 173 patients who had undergone radical retropubic prostatectomy at our Institution. Patients were divided into 25 groups, depending on preoperative PSA and the biopsy Gleason score. The risk of extracapsular neoplastic growth, seminal vesicle involvement and lymph node involvement was calculated for each group by means of Roach's equations. On the basis of definitive histological examinations, we compared the expected risk to the observed risk. Results: The observed risk fell within the interval of expected risk in 16 of 17 groups (94%) regarding the evaluation of extracapsular growth, in 15 of 17 (88%) regarding the analysis of seminal vesicle involvement, and in 14 of 17 (82%) regarding the evaluation of lymph node involvement. Therefore, the observed event was In agreement with the expected event in 45 of 51 groups (88%). Conclusions: The equations represent a practical and effective instrument for preoperative clinical staging in patients with localized prostate cancer. By means of these mathematical formulas, one can assess the correct prognosis and - above all plan the best therapeutic approach.
引用
收藏
页码:130 / 133
页数:4
相关论文
共 50 条
  • [21] Prostatectomy and survival among men with clinically localized prostate cancer
    Lawrence, G
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (21): : 1724 - 1724
  • [22] Nomograms to predict the pathological stage of clinically localized prostate cancer in Korean men: Comparison with Western predictive tools using decision curve analysis
    Jeong, Chang Wook
    Jeong, Seong Jin
    Hong, Sung Kyu
    Lee, Seung Bae
    Ku, Ja Hyeon
    Byun, Seok-Soo
    Jeong, Hyeon
    Kwak, Cheol
    Kim, Hyeon Hoe
    Lee, Eunsik
    Lee, Sang Eun
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 (09) : 846 - 852
  • [23] Predicting survival for men with clinically localized prostate cancer - What do we need in contemporary practice?
    Albertsen, Peter
    CANCER, 2008, 112 (01) : 1 - 3
  • [24] Nomogram for predicting survival in men with clinically localized prostate cancer who do not undergo definitive therapy
    Klotz, L.
    NATURE CLINICAL PRACTICE UROLOGY, 2008, 5 (07): : 362 - 363
  • [25] Nomogram for predicting survival in men with clinically localized prostate cancer who do not undergo definitive therapy
    Laurence Klotz
    Nature Clinical Practice Urology, 2008, 5 : 362 - 363
  • [26] SONOGRAPHIC AND PATHOLOGICAL STAGING OF PATIENTS WITH CLINICALLY LOCALIZED PROSTATE-CANCER
    ANDRIOLE, GL
    COPLEN, DE
    MIKKELSEN, DJ
    CATALONA, WJ
    JOURNAL OF UROLOGY, 1989, 142 (05): : 1259 - 1261
  • [27] Racial differences in prostate androgen levels in men with clinically localized prostate cancer
    Mohler, JL
    Gaston, KE
    Moore, DT
    Schell, MJ
    Cohen, BR
    Petrusz, P
    JOURNAL OF UROLOGY, 2004, 171 (04): : 221 - 221
  • [28] Racial differences in prostate androgen levels in men with clinically localized prostate cancer
    Mohler, JL
    Gaston, KE
    Moore, DT
    Schell, MJ
    Cohen, BL
    Weaver, C
    Petrusz, P
    JOURNAL OF UROLOGY, 2004, 171 (06): : 2277 - 2280
  • [29] Testosterone as a predictor of pathologic stage in clinically localized prostate cancer
    Isom-Batz, G
    Bianco, FJ
    Kattan, MW
    Mulhall, JP
    Eastham, JA
    JOURNAL OF UROLOGY, 2005, 173 (04): : 384 - 385
  • [30] THE USE OF PROSTATE-SPECIFIC ANTIGEN, CLINICAL STAGE AND GLEASON SCORE TO PREDICT PATHOLOGICAL STAGE IN MEN WITH LOCALIZED PROSTATE-CANCER
    PARTIN, AW
    WALSH, PC
    JOURNAL OF UROLOGY, 1994, 152 (01): : 172 - 173